23 results
Thumbnail

D2.63 - Airborne allergic contact dermatitis in a textile worker: role of formaldehyde and methylisothiazolinones

Thumbnail

D2.64 - Occupational allergic contact dermatitis due to rubber additives: clinical features and occupational implications

Thumbnail

D2.72 - Radiological heterogeneity and inflammatory phenotypes in allergic bronchopulmonary aspergillosis

Thumbnail

D2.58 - Nickel Sensitization and Reversible Airway Dysfunction: Evidence from Pulmonary Function Response to Nickel Avoidance

Thumbnail

D2.59 - Refining Quality of Life Assessment in CSU: Validation and Threshold Determination of the CU-Q2oL questionnaire

Thumbnail

D2.61 - Allergic Contact Dermatitis Due to Disperse Textile Dyes: A 10-Year Review

Thumbnail

D2.62 - Atypical Chronic Cheilitis as Manifestation of Atopic Dermatitis: A Diagnostic Dilemma

Thumbnail

D2.65 - Allergic cheilitis related to vaginal lubricant: a case report

Thumbnail

D2.66 - Allergic contact dermatitis to cobalt and concomitant sensitization to nickel and chromium

Thumbnail

D2.67 - Clinical Profile of Allergic Contact Dermatitis in Workers and Factors Associated with Occupational Outcomes

Thumbnail

D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region

Thumbnail

D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor

Thumbnail

D3.155 - Th2–Th17 immune shift following dupilumab therapy

Thumbnail

D3.160 - Study of the allergic sensitization profile in asthmatic patients consulting at ignace deen university hospital, conakry

Thumbnail

D3.164 - Early and Sustained Effect of Zumilokibart (APG777) in Atopic Dermatitis and Asthma: 16-Week Results from the Phase 2 APEX Study in Moderate-to-Severe AD and a Phase 1b Study in Mild-to-Moderate Asthma

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project